My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 4 results for

GO
Search Filters: Massachusetts cancel Rhode Island cancel Florida cancel Maryland cancel

Domestic Holiday Travel Pandemic Restrictions and Recommendations

Blog,
Health Policy Update,
Infectious Disease,
COVID-19,
COVID and Community Mitigation,
COVID and Law/Policy,
COVID Preparedness,
Health Equity,
Tribal Health,
Preparedness,
Emergency Powers,
Policy,
State Health Policy,
Territories and Freely Associated States,
Alabama,
Alaska,
American Samoa,
Arizona,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Washington, D.C.,
Federated States of Micronesia,
Florida,
Georgia,
Guam,
Hawaii,
Idaho,
Illinois,
Indiana,
Iowa,
Kansas,
Kentucky,
Louisiana,
Maine,
Marshall Islands,
Maryland,
Massachusetts,
Michigan,
Minnesota,
Mississippi,
Missouri,
Montana,
Nebraska,
Nevada,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Carolina,
North Dakota,
Northern Mariana Islands,
Ohio,
Oklahoma,
Oregon,
Palau,
Pennsylvania,
Puerto Rico,
Rhode Island,
South Carolina,
South Dakota,
Tennessee,
Texas,
Utah,
Vermont,
Virgin Islands,
Virginia,
Washington,
West Virginia,
Wisconsin,
Wyoming,
Maggie Davis

The 2020 holiday season is coinciding with a nationwide surge of COVID-19 cases. With great concern that holiday travel to see loved ones may exacerbate community spread of the virus, many states are increasing public health measures ...

Jurisdictions Moving Many ASTHO Essential Tobacco Control Policies Forward

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Tobacco Control,
Chronic Disease Prevention and Health Improvement,
Health Equity,
Elimination of Disparities,
Alaska,
American Samoa,
California,
Florida,
Georgia,
Guam,
Hawaii,
Illinois,
Iowa,
Kentucky,
Louisiana,
Maryland,
Massachusetts,
Mississippi,
Nebraska,
New Jersey,
New Mexico,
New York,
Northern Mariana Islands,
Oregon,
Puerto Rico,
Rhode Island,
Tennessee,
Virgin Islands,
Washington,
Washington, D.C.,
West Virginia,
Wisconsin,
Joshua Berry,
Ann Abraham,
Territories and Freely Associated States,
Evidence or Fact-Based Measures

Over the past several years, states and jurisdictions have continued to implement important policies to reduce tobacco and nicotine use, including increasing tobacco prices, expanding areas deemed “smoke-free,” limiting the sale of ...

State/Territorial Policy Considerations for Preventing Adverse Childhood Experiences

Report,
Policy,
State Health Policy,
Population Health and Prevention,
Women, Infant, and Family Health,
ACEs,
Health Equity,
At-Risk Populations,
Social Determinants of Health,
Social and Behavioral Health,
Injury and Violence Prevention,
Alaska,
Arizona,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Florida,
Hawaii,
Idaho,
Illinois,
Maine,
Maryland,
Massachusetts,
Michigan,
Minnesota,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Dakota,
Ohio,
Oregon,
Rhode Island,
Tennessee,
Texas,
Vermont,
Virginia,
Washington,
Washington, D.C.,
Youth Mental Health,
LGBTQ+,
Firearm Injury and Violence Prevention

ASTHO staff identified a range of evidence-supported policies considered by state legislatures that could prevent ACEs. This report synthesizes these research and policy proposals and is intended for public health practitioners and ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...